Viewing StudyNCT00216112



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00216112
Status: COMPLETED
Last Update Posted: 2016-02-19
First Post: 2005-09-12

Brief Title: Imatinib Mesylate in Combination With Docetaxel for Advanced Platinum-Refractory Ovarian Cancer
Sponsor: Daniela Matei MD
Organization: Hoosier Cancer Research Network

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-12
Start Date Type: None
Primary Completion Date: 2005-10
Primary Completion Date Type: ACTUAL
Completion Date: 2007-07
Completion Date Type: ACTUAL
First Submit Date: 2005-09-12
First Submit QC Date: September 14 2005
Study First Post Date: 2005-09-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-02-17
Last Update Post Date: 2016-02-19
Last Update Post Date Type: ESTIMATED